Arctic Fish Antifreeze Improves Type 1 Diabetes Treatment    

(Source)

HealtheSolutions.com-Cause-Cure-Type-1-Diabetes-Arctic Fish AntifreezeAn Arctic fish antifreeze glycopeptide that mimics a naturally occurring glycoprotein found in Arctic fish is helping to significantly improve the efficacy of cell transplant treatments for diabetes patients – a procedure that transplants insulin producing islets to render them insulin independent for periods of time.

Anti-aging Glycopeptide (AAGP™) is the focus of a new study published in the journal Diabetes. Researchers from the University of Alberta’s Faculty of Medicine & Dentistry found that by soaking islet cells in AAGP™ for an hour and then washing it off prior to transplantation, the cells were protected from tacrolimus – an antirejection drug commonly used during transplants that is toxic to islets cells.

“Normally when we expose human islets to tacrolimus in the petri dish, they flat line and don’t release insulin at all,” says James Shapiro, senior author of the study and Canada Research Chair in Transplant Surgery and Regenerative Medicine at the U of A. “When we add the AAGP™ and wash it all off, the cells work perfectly normally, and are protected in a remarkably durable manner. We find we need far fewer cells to treat diabetes in our preclinical models than we would normally.”

Since his creation of the Edmonton Protocol in 1999, more than 250 patients have been treated by Shapiro through islet cell transplantation. A key challenge of the procedure though is that most patients typically need two islet infusions, each prepared from a separate pancreas organ donor. Shapiro says there aren’t enough organ donors to meet demand. Through the use AAGP™, a greater number of islet cells will survive the procedure, potentially allowing more patients to be treated.

“Just a one-hour soak in AAGP™ is enough to protect the islet cells for up to a month or two afterwards. It has a very potent and profound effect,” says Shapiro. “As a direct result of these findings, we’re now moving forward with plans for a first in human clinical trial, testing this drug in our human islet cell transplant program.”

“This synthetic molecule seems to provide significant protection to cells exposed to multiple deleterious conditions, such as UV radiation, starvation, extreme temperatures andoxidative stress,” says Boris Gala-Lopez, lead author of the study and a clinical/research fellow at the U of A’s Department of Surgery. “We are certainly very excited for the multiple opportunities this finding entails to the field of transplantation research.”

If proven successful in human clinical trials, Shapiro believes the inclusion of AAGP™ could soon become a permanent addition to the Edmonton Protocol, representing a significant step forward in the treatment of Type 1 diabetes through islet transplantation. While more research is needed, he also believes the drug shows promise for a wide range of transplantations, potentially working to protect organs as effectively as it protects islets.

Health-e-Solutions comment: Who knew arctic fish contained a key antifreeze glycopeptide that could help make islet transplantation a safer procedure?

Health-e-Solutions-Outlook-Arctic Fish AntifreezeUntil we have a #Type1DiabetesCure, it is our opinion that to #MasterDiabetes in the healthiest way possible through lifestyle innovations as a priority over drug therapies is vital. It is important for optimal #BloodSugarControl today, but it can help put your body in a position of strength for tomorrow – for that day when a #Type1DiabetesCure may be found. Our recipe e-books, workshops and home study course will teach you how to transform your lifestyle in a #PracticalLivableSustainable way for better living. Our support services can make the difference between success and failure during your transformation. And our Natural Solutions will take you deeper into practical application and underlying research. Let us help you shorten the learning curve to successful lifestyle transformation by setting you on the path toward optimal blood sugar control and better living.

Journal Reference: B. L. Gala-Lopez, A. R. Pepper, R. L. Pawlick, D. O’Gorman, T. Kin, A. Bruni, N. Abualhassan, M. Bral, A. Bautista, J. E. Manning Fox, L. G. Young, P. E. MacDonald, A. Shapiro. Anti-aging Glycopeptide Protects Human Islets Against Tacrolimus-related Injury and Facilitates Engraftment in MiceDiabetes, 2015; DOI: 10.2337/db15-0764